Hangxiang Du

726 total citations
16 papers, 347 citations indexed

About

Hangxiang Du is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Hangxiang Du has authored 16 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Hangxiang Du's work include COVID-19 Clinical Research Studies (5 papers), Sepsis Diagnosis and Treatment (3 papers) and Pneumonia and Respiratory Infections (2 papers). Hangxiang Du is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Sepsis Diagnosis and Treatment (3 papers) and Pneumonia and Respiratory Infections (2 papers). Hangxiang Du collaborates with scholars based in China and France. Hangxiang Du's co-authors include Lidi Zhang, Yizhu Chen, Zhenliang Wen, Dechang Chen, Jiao Liu, Xuan Dong, Yongan Liu, Jieming Qu, Limin Chen and Sisi Huang and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Hangxiang Du

16 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hangxiang Du China 9 190 110 101 59 55 16 347
Shuliang Zhou China 8 229 1.2× 133 1.2× 75 0.7× 53 0.9× 101 1.8× 13 410
Tangxi Guo China 6 234 1.2× 123 1.1× 55 0.5× 38 0.6× 96 1.7× 6 354
Ding Long China 7 225 1.2× 105 1.0× 43 0.4× 35 0.6× 82 1.5× 19 370
Guorong Gu China 7 179 0.9× 95 0.9× 78 0.8× 14 0.2× 52 0.9× 15 357
Chaoyuan Jin China 6 181 1.0× 96 0.9× 44 0.4× 14 0.2× 53 1.0× 9 269
Xiuqi Wei China 8 259 1.4× 90 0.8× 110 1.1× 53 0.9× 75 1.4× 13 431
Jingyu Su China 5 229 1.2× 71 0.6× 91 0.9× 45 0.8× 63 1.1× 10 359
Navid Ahmadi Poland 6 165 0.9× 89 0.8× 40 0.4× 16 0.3× 88 1.6× 11 314
Jun Xiong China 4 228 1.2× 118 1.1× 39 0.4× 10 0.2× 78 1.4× 4 324
Jipin Jiang China 9 129 0.7× 64 0.6× 46 0.5× 10 0.2× 48 0.9× 31 317

Countries citing papers authored by Hangxiang Du

Since Specialization
Citations

This map shows the geographic impact of Hangxiang Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hangxiang Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hangxiang Du more than expected).

Fields of papers citing papers by Hangxiang Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hangxiang Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hangxiang Du. The network helps show where Hangxiang Du may publish in the future.

Co-authorship network of co-authors of Hangxiang Du

This figure shows the co-authorship network connecting the top 25 collaborators of Hangxiang Du. A scholar is included among the top collaborators of Hangxiang Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hangxiang Du. Hangxiang Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zhang, Sheng, Weifeng Shang, Hangxiang Du, et al.. (2025). Network pharmacology, molecular docking, and experimental verification reveal the mechanism of Yi-Shen-Hua-Shi granules treating acute kidney injury. Journal of Ethnopharmacology. 343. 119320–119320. 2 indexed citations
2.
Liu, Jiao, Sheng Zhang, Sisi Huang, et al.. (2021). Rationality of Time-Dependent Antimicrobial Use in Intensive Care Units in China: A Nationwide Cross-Sectional Survey. Frontiers in Medicine. 8. 584813–584813. 7 indexed citations
3.
Zhang, Sheng, Sisi Huang, Jiao Liu, et al.. (2021). Identification and validation of prognostic factors in patients with COVID-19: A retrospective study based on artificial intelligence algorithms. SHILAP Revista de lepidopterología. 1(2). 103–109. 11 indexed citations
4.
Du, Hangxiang, Wenzhe Li, Yongan Liu, et al.. (2021). Effect of Nebulized Amphotericin B in Critically ill Patients With Respiratory Candida spp. De-colonization: A Retrospective Analysis. Frontiers in Medicine. 8. 723904–723904. 4 indexed citations
5.
Meng, Mei, Limin Chen, Sheng Zhang, et al.. (2021). Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients. BMC Infectious Diseases. 21(1). 398–398. 15 indexed citations
6.
Liu, Jiao, Yizhu Chen, Ranran Li, et al.. (2021). Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multicentre study. Clinical Microbiology and Infection. 27(10). 1488–1493. 14 indexed citations
7.
Liu, Jiao, Sheng Zhang, Xuan Dong, et al.. (2020). Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome. Journal of Clinical Investigation. 130(12). 6417–6428. 91 indexed citations
8.
Liu, Jiao, Lidi Zhang, Yizhu Chen, et al.. (2020). Association of sex with clinical outcomes in COVID-19 patients: A retrospective analysis of 1190 cases. Respiratory Medicine. 173. 106159–106159. 15 indexed citations
9.
Liu, Jiao, Jianying Yao, Lidi Zhang, et al.. (2020). Surfactant protein D (SP-D) gene polymorphism rs721917 is an independent predictor of acute kidney injury development in sepsis patients: a prospective cohort study. Annals of Intensive Care. 10(1). 5–5. 1 indexed citations
10.
Liu, Jiao, Sheng Zhang, Zhixiong Wu, et al.. (2020). Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study. Annals of Intensive Care. 10(1). 99–99. 86 indexed citations
11.
Liu, Jiao, Yongan Liu, Lidi Zhang, et al.. (2020). Down‐regulation of circDMNT3B is conducive to intestinal mucosal permeability dysfunction of rats with sepsis via sponging miR‐20b‐5p. Journal of Cellular and Molecular Medicine. 24(12). 6731–6740. 21 indexed citations
12.
Liu, Jiao, Yu Zhou, Minmin Wang, et al.. (2020). [Application of continuous renal replacement therapy in coronavirus disease 2019].. PubMed. 32(5). 618–621. 1 indexed citations
13.
Yan, Xuebing, Qingchao Zhu, Hongqi Chen, et al.. (2014). Knockdown of Y-box-binding protein-1 inhibits the malignant progression of HT-29 colorectal adenocarcinoma cells by reversing epithelial-mesenchymal transition. Molecular Medicine Reports. 10(5). 2720–2728. 11 indexed citations
14.
Wang, Zhigang, Xiaoping Zhang, Zhili Yang, et al.. (2012). MiR-145 regulates PAK4 via the MAPK pathway and exhibits an antitumor effect in human colon cells. Biochemical and Biophysical Research Communications. 427(3). 444–449. 60 indexed citations
15.
Du, Hangxiang, Gewen Tan, Zhili Yang, & Zhigang Wang. (2012). [Meta-analysis of laparoscopic Nissen and Toupet fundoplication for gastro-oesophageal reflux disease].. PubMed. 15(8). 814–8. 3 indexed citations
16.
Du, Hangxiang, et al.. (2011). Separation of Circulating Cancer Cells by Unique Microfluidic Chip in Colorectal Cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 19(10). 487–500. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026